secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001493152-26-001234
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot Medical reaffirms 2025 achievements, outlines 2026 milestones including Full Market Release in Q2
--------------------------------------------------------------------------------

- Received FDA 510(k) clearance for LIBERTY, first single-use remotely operated robotic system for peripheral endovascular procedures.
- Emory University Hospital became first adopter of LIBERTY under Limited Market Release; 100% robotic navigation success in ACCESS PVI trial.
- Full Market Release of LIBERTY planned for Q2 2026, coinciding with SIR conference.
- Targeting 2.5 million annual peripheral endovascular procedures in U.S.; building pipeline for cardiology and neurovascular spaces.
- Expanded IP portfolio to 20 patents granted, 52 applications pending; balance sheet bolstered with non-dilutive grant.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000149315226001234/0001493152-26-001234-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000149315226001234/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-001234

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer